Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Clinical trial NCT00335881 · COMPLETED
Trial details
- NCT number
- NCT00335881
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.